ResearcherSun Yat-sen UniversityActive in the last 2 years
Zhenfeng Tian
Matched on OpenAlex author ID A5082090488. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 3 papers
Papers 7
- KRAS/ACTN4/p65-NR2A axis mediates glutamine-glutamate metabolic coupling between schwann cells and pancreatic cancer promoting perineural invasion. Co-author DOI 10.1016/j.jare.2025.10.030↗
- Corrigendum to "Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR axis" [Translational Resea… Co-author DOI 10.1016/j.trsl.2026.09.008↗
- Dynamic feedback between IL-6 and TWIST1 drives pancreatic cancer progression. Co-author DOI 10.21037/tgh-2026-0021↗
- Identification of gemcitabine resistance-related AHNAK2 gene associated with prognosis and immune infiltration in pancreatic cancer. First author DOI 10.1016/j.heliyon.2024.e33687↗
- Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR axis. Co-author DOI 10.1016/j.trsl.2022.11.007↗
- TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion. Co-author DOI 10.1016/j.canlet.2022.215863↗
- TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. Co-author DOI 10.1016/j.bcp.2020.114085↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Guangsheng Ou · 5 shared papers, 2022–2026 · strength 1.21
- Paper Corrigendum to "Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/… DOI 10.1016/j.trsl.2026.09.008↗
- Paper Dynamic feedback between IL-6 and TWIST1 drives pancreatic cancer progression. DOI 10.21037/tgh-2026-0021↗
- Paper Identification of gemcitabine resistance-related AHNAK2 gene associated with prognosis and immune infiltration in pancr… DOI 10.1016/j.heliyon.2024.e33687↗
- Yinting Chen · 5 shared papers, 2021–2026 · strength 1.09
- Paper KRAS/ACTN4/p65-NR2A axis mediates glutamine-glutamate metabolic coupling between schwann cells and pancreatic cancer pr… DOI 10.1016/j.jare.2025.10.030↗
- Paper Identification of gemcitabine resistance-related AHNAK2 gene associated with prognosis and immune infiltration in pancr… DOI 10.1016/j.heliyon.2024.e33687↗
- Paper Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR ax… DOI 10.1016/j.trsl.2022.11.007↗
- Xingyi Lin · 4 shared papers, 2022–2026 · strength 0.96
- Paper Corrigendum to "Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/… DOI 10.1016/j.trsl.2026.09.008↗
- Paper Dynamic feedback between IL-6 and TWIST1 drives pancreatic cancer progression. DOI 10.21037/tgh-2026-0021↗
- Paper Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR ax… DOI 10.1016/j.trsl.2022.11.007↗
- Ying Tan · 3 shared papers, 2021–2026 · strength 0.64
- Paper Corrigendum to "Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/… DOI 10.1016/j.trsl.2026.09.008↗
- Paper Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR ax… DOI 10.1016/j.trsl.2022.11.007↗
- Paper TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. DOI 10.1016/j.bcp.2020.114085↗
- Yinting Chen · 2 shared papers, 2026 · strength 0.62
- Miao Yu · 1 shared paper, 2026 · strength 0.36
- Miao Yu · 1 shared paper, 2026 · strength 0.30
- Jinmao Zou · 2 shared papers, 2021–2022 · strength 0.28
- Paper TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion. DOI 10.1016/j.canlet.2022.215863↗
- Paper TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. DOI 10.1016/j.bcp.2020.114085↗
- Shangxiang Chen · 2 shared papers, 2021–2022 · strength 0.28
- Paper TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion. DOI 10.1016/j.canlet.2022.215863↗
- Paper TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. DOI 10.1016/j.bcp.2020.114085↗
- Kaihong Huang · 2 shared papers, 2021–2022 · strength 0.28
- Paper TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion. DOI 10.1016/j.canlet.2022.215863↗
- Paper TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. DOI 10.1016/j.bcp.2020.114085↗
- Yaqing Li · 1 shared paper, 2022 · strength 0.15
- Shaojie Chen · 1 shared paper, 2021 · strength 0.13
- Guoda Lian · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.